The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Noninvasive Detection of Misfolded Proteins in the Brain Using [11C]BF-227 PET
|
|
Author(s): Nobuyuki Okamura (Tohoku University, Japan), Shozo Furumoto (Tohoku University, Japan), Manabu Tashiro (Tohoku University, Japan), Katsutoshi Furukawa (Tohoku University, Japan), Hiroyuki Arai (Tohoku University, Japan), Yukitsuka Kudo (Tohoku University, Japan)and Kazuhiko Yanai (Tohoku University, Japan)
Copyright: 2013
Pages: 8
Source title:
Bioinformatics: Concepts, Methodologies, Tools, and Applications
Source Author(s)/Editor(s): Information Resources Management Association (USA)
DOI: 10.4018/978-1-4666-3604-0.ch025
Purchase
|
Abstract
Alzheimer’s disease (AD) and many other neurodegenerative disorders belong to the family of protein misfolding diseases. These diseases are characterized by the deposition of insoluble protein aggregates containing an enriched ß-sheet structure. To evaluate PET amyloid-imaging tracer [11C]BF-227 as an agent for in vivo detection of various kinds of misfolded protein, a [11C]BF-227 PET study was performed in patients with various protein misfolding diseases, including AD, frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Sträussler-Scheinker disease (GSS). BF-227 binds to ß-amyloid fibrils with high affinity. Most of the AD patients showed prominent retention of [11C]BF-227 in the neocortex. In addition, neocortical retention of BF-227 was observed in the subjects with mild cognitive impairment who converted to AD during follow-up. DLB patients had elevated [11C]BF-227 uptake in the neocortex. However, FTD and sCJD patients showed no cortical retention of [11C]BF-227. Patients with multiple system atrophy had elevated BF-227 binding in the putamen. Finally, GSS patients had elevated BF-227 uptake in the cerebellum and other brain regions. This chapter confirms that BF-227 can selectively bind to a-synuclein and prion protein deposits using postmortem brain samples. Based on these findings, [11C]BF-227 is not necessarily specific for ß-amyloid in AD patients. However, this tracer could be used to detect various types of protein aggregates in the brain.
Related Content
|
Linkon Chowdhury, Md Sarwar Kamal, Shamim H. Ripon, Sazia Parvin, Omar Khadeer Hussain, Amira Ashour, Bristy Roy Chowdhury.
© 2024.
20 pages.
|
|
Mousomi Roy.
© 2024.
21 pages.
|
|
Nassima Dif, Zakaria Elberrichi.
© 2024.
20 pages.
|
|
Pyingkodi Maran, Shanthi S., Thenmozhi K., Hemalatha D., Nanthini K..
© 2024.
16 pages.
|
|
Mohamed Nadjib Boufenara, Mahmoud Boufaida, Mohamed Lamine Berkane.
© 2024.
16 pages.
|
|
Meroua Daoudi, Souham Meshoul, Samia Boucherkha.
© 2024.
25 pages.
|
|
Zhongyu Lu, Qiang Xu, Murad Al-Rajab, Lamogha Chiazor.
© 2024.
56 pages.
|
|
|